» Articles » PMID: 14734504

Endothelial Dysfunction in Pulmonary Hypertension

Overview
Journal Circulation
Date 2004 Jan 22
PMID 14734504
Citations 276
Authors
Affiliations
Soon will be listed here.
Citing Articles

Omega-6 polyunsaturated fatty acids and their metabolites: a potential targeted therapy for pulmonary hypertension.

Wang J, Hu S, Xu Y, Wang T Respir Res. 2025; 26(1):102.

PMID: 40089708 DOI: 10.1186/s12931-025-03172-2.


The role of lactate metabolism and lactylation in pulmonary arterial hypertension.

Peng T, Lu J, Zheng X, Zeng C, He Y Respir Res. 2025; 26(1):99.

PMID: 40075458 PMC: 11905457. DOI: 10.1186/s12931-025-03163-3.


Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease.

Yang H, Li J, Song C, Li H, Luo Q, Chen M Int J Mol Sci. 2025; 26(4).

PMID: 40004206 PMC: 11855571. DOI: 10.3390/ijms26041743.


Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing.

Tarras E, Singh I, Kreiger J, Joseph P J Clin Med. 2025; 14(3).

PMID: 39941482 PMC: 11818252. DOI: 10.3390/jcm14030804.


Targeting Soluble TGF-β Factors: Advances in Precision Therapy for Pulmonary Arterial Hypertension.

Becher C, Wits M, de Man F, Sanchez-Duffhues G, Goumans M JACC Basic Transl Sci. 2024; 9(11):1360-1374.

PMID: 39619136 PMC: 11604486. DOI: 10.1016/j.jacbts.2024.04.005.